Conventional radiotherapy, in addition to its well-established tumoricidal effects, can also
activate the host immune system. Radiation therapy modulates tumour phenotypes …

Surgical resection remains the only effective means of cure in the vast majority of patients
with early‐stage lung cancer. It can be performed via a traditional open approach …

Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC)
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …

Non–small cell lung cancer (NSCLC) is the leading cause of cancer‐related death in the
United States. With the implementation of lung cancer screening, the number and proportion …

Advances in image-guided radiotherapy (RT) have allowed for dose escalation and more
precise radiation treatment delivery. Each decade brings new imaging technologies to help …

Purpose In early-stage non–small cell lung cancer (NSCLC), post-treatment mortality may
influence the comparative effectiveness of surgery and stereotactic body radiotherapy …

Image-guided stereotactic ablative radiotherapy (SABR; also called stereotactic body
radiotherapy or radiosurgery) has become a standard treatment for medically inoperable …

Radiation dose escalation has been shown to improve local control and survival in patients
with non–small cell lung cancer in some studies, but randomized data have not supported …

Purpose As no completed randomized trials of surgery versus stereotactic ablative radiation
therapy (SABR) in patients with early-stage non-small cell lung cancer are available …

The use of stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung
cancer is growing rapidly, particularly since it has become the recommended therapy for …